Revenio Group Oyj (LON:0KFH)
20.82
-1.88 (-8.29%)
Jan 21, 2026, 4:37 PM GMT
Revenio Group Oyj Revenue
In the year 2025, Revenio Group Oyj had annual revenue of 109.90M EUR with 5.86% growth. Revenio Group Oyj had revenue of 31.30M in the quarter ending December 31, 2025, with 1.89% growth.
Revenue
109.90M EUR
Revenue Growth
+5.86%
P/S Ratio
4.42
Revenue / Employee
443.15K EUR
Employees
248
Market Cap
424.10M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.90M | 6.08M | 5.86% |
| Dec 31, 2024 | 103.82M | 7.04M | 7.27% |
| Dec 31, 2023 | 96.79M | -445.00K | -0.46% |
| Dec 31, 2022 | 97.23M | 17.88M | 22.53% |
| Dec 31, 2021 | 79.36M | 18.04M | 29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Advanced Medical Solutions Group | 220.30M |
| Craneware | 150.11M |
| Integrated Diagnostics Holdings | 114.96M |
| Allergy Therapeutics | 55.04M |
Revenio Group Oyj News
- 3 months ago - Revenio Group Oyj 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Revenio Group Oyj (REVXF) Q3 2025 Earnings Call Highlights: Strong European Growth and ... - GuruFocus
- 3 months ago - Revenio Group Oyj (REVXF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Q3 2025 Revenio Group Oyj Earnings Call Transcript - GuruFocus